|

Cetrelimab Clinical Trials

6 actively recruiting trials across 5 locations

▲ +1 trial since May 2026

Also known as: JNJ-63723283

Pipeline

Phase 1: 5Phase 2: 1

Top Sponsors

  • Johnson & Johnson Enterprise Innovation Inc.3
  • University Medical Center Groningen1
  • Janssen Research & Development, LLC1
  • Ankyra Therapeutics, Inc1

Indications

  • Cancer6
  • Neoplasms2
  • Lung Cancer2
  • Metastatic Hormone-sensitive Prostate Cancer1
  • Metastatic Castration-resistant Prostate Neoplasms1

Other1 trial

CD8 PET Imaging in Metastatic Solid Tumours
Phase 2

Sarasota, Florida1 trial

A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate Cancer

Florida Cancer Specialists

Phase 1

Newnan, Georgia1 trial

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

City of Hope 1

Phase 1

Indianapolis, Indiana1 trial

A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer

Community Health Network

Phase 1

New York, New York1 trial

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

NYU Langone Health

Phase 1

The Bronx, New York1 trial

A Study of JNJ-1761981 in Participants With Solid Tumors

Montefiore Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.